Login / Signup
A new era after a long wait: Vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes in patients with IDH-mutant glioma.
Antonio Silvani
Enrico Franceschi
Published in:
Tumori (2024)
Keyphrases
</>
wild type
low grade
high grade